Technical Feasibility Study of a Novel Wearable Capnograph (MARIE) in an Emergency Care Environment, Part 1

You have been assessed by paramedics as needing to go to the emergency department. During transport, the paramedics will monitor you by, for example, measuring your blood pressure and checking your pulse. In healthcare, we are constantly working to improve and optimize the degree of monitoring during ambulance transports and through this also be able to start adequate treatment earlier. In this case, we are working to understand whether exhaled carbon dioxide levels can be used to monitor important processes in the body during ambulance transport. Therefore, we offer you to participate in a project that deals with whether we can use a new equipment to measure and monitor exhaled carbon dioxide during the journey to hospital. This clinical trial is being conducted in Region Uppsala in collaboration with Oxlantic Medical AB. The main responsible and Sponsor for the trial is Oxlantic Medical AB. The research lead for the trial is Region Uppsala and Uppsala University. This clinical trial has been subject to ethical review and approved by the Ethics Review Authority.

NCT Number	NCT06905613
Lead Sponsor	Uppsala University Collaborators: Uppsala University Hospital
Conditions	Technical Feasibility, Ambulances
Enrollment	49 participants
Start Date	2024-12-19
Primary Completion	2025-01-31 (estimated)
Study Completion	2025-03-28 (estimated)
Updated on ClinicalTrials.gov	2026-05-06